Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05719220 · ClinicalTrials.gov registry record
Effect of Group Preoperative Pelvic Floor Training for HoLEP
A clinical trial of Urinary Incontinence and BPH, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05719220: Recruiting study of Urinary Incontinence and BPH, sponsored by University of California, San Francisco.
NCT05719220 is a study of Urinary Incontinence and BPH that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 260-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05719220, a study of Urinary Incontinence and BPH, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The main goal of this study is to see if group pelvic floor training before surgery can help prevent urinary incontinence after Holmium laser enucleation of the prostate (HoLEP) surgery. The study has the potential to inform preoperative intervention strategies for managing incontinence after HoLEP.
Primary Outcome
Urinary incontinence (present/absent) will be defined according to the guidelines of the International Continence Society as involuntary loss of urine experienced during the bladder storage phase using self-report measures at regular intervals postoperatively.
Conditions Studied
Interventions
- BEHAVIORAL Group preoperative pelvic floor training
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2026-03-30 |
What NCT05719220 shows while recruiting
NCT05719220 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 260-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (62% lower).
The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Group preoperative pelvic floor training is the first listed.
NCT05719220 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05719220 about?
NCT05719220 is a clinical study titled "Effect of Group Preoperative Pelvic Floor Training for HoLEP". The main goal of this study is to see if group pelvic floor training before surgery can help prevent urinary incontinence after Holmium laser enucleation of the prostate (HoLEP) surgery. The study has the potential to inform preoperative intervention strategies for managing incontinence after HoLEP.
What is the current status of trial NCT05719220?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-02-07. Estimated completion is 2026-03-30.
What conditions does trial NCT05719220 study?
This clinical trial studies the following conditions: Urinary Incontinence, BPH.
What interventions are being tested in trial NCT05719220?
The interventions under investigation include: Group preoperative pelvic floor training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05719220?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05719220 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05719220's enrollment target sits among peer trials
100 24th of 48 higher than 24 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI